Article

Nanomedicine: how it could reshape clinical practice.

Nanomedicine (Impact Factor: 5.26). 09/2007; 2(4):401-5. DOI: 10.2217/17435889.2.4.401
Source: PubMed
0 Bookmarks
 · 
44 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: La medicina non è complessa solo perché è un insieme di scienza e di arte, di natura e di cultura, ma, prima di tutto, perché racchiude in sé una realtà fondamentalmente multidisciplinare, quella delle scienze della vita, che oggi estende l'ambito del sapere medico oltre i confini finora tradizionali. È ormai consapevolezza diffusa che l'agire medico non è più possibile senza un costan-te richiamo ad aree di conoscenza che estendono di molto quelli che fino a qualche decennio fa sono stati i riferimenti culturali della patologia e della clinica. Riassunto. La sviluppo della medicina come scienza avviene sempre più in un ambito multidisciplinare che prende il nome di scienze della vita. L'innovazione biotecnologica sta cambiando la comprensione della patologia e la stessa terapia medica. Questo com-porta anche un cambiamento del ruolo del medico, che va di pari passo con la afferma-zione della centralità del cittadino malato nel sistema sanitario. Anche la medicina ba-sata sulle evidenze scientifiche, seppur ancora valida per le scelte di politica sanitaria, non è più considerata pienamente adatta alla gestione del singolo malato. Un approccio genomico e soprattutto post-genomico potrebbe favorire la nascita di una vera medicina personalizzata, ma per poter sfruttare in pieno le enorme mole di nuove informazioni messe a disposizione dalle nuove tecniche "omiche" è necessario lo sviluppo di nuovi stru-menti bioinformatici idonei a gestire una capacità di calcolo potenzialmente infinita tra-mite reti a griglia (Grid computing). Lo sviluppo delle scienze della vita comporta nuove necessità formative e professionali per il medico. L'accostamento tra Centri clinici e Cen-tri di ricerca in medicina molecolare è esempio sempre più diffuso che può favorire la co-noscenza traslazionale e lo sviluppo della scienza medica verso orizzonti fino a poco tem-po fa inimmaginabili. Parole chiave. Genomica, Grid computing, medicina molecolare, proteomica, scienza translazionale, transcrittomica. Summary. Life sciences: a new area of action for the physician. The development of the medical knowledge has became a multidisciplinary process that can be called life sciences. The new biotechnologies are changing the insight of pathology and medical therapy itself. So, the rule of the physician is changing together with the overwhelming centrality of the patient into the health system. Also, the evidence based medicine is no more considered a crucial task for the physician who cares the sin-gle ill person, albeit its importance is still high for health organizations. A genomic and post-genomic approach could indeed help to create an actual personalised medicine. Nev-ertheless, "omics" probably need the development of new bioinformatic tools capable to manage a huge amount of data by means of Grid computing. The development of the life sciences involves new formative and professional needs for the physician. The transla-tional knowledge can be favoured by the closeness of clinical centres and basic science ar-eas as suggested by several examples spreading all over the world. These experiences could open new exciting horizons for the medical science.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Labeling of food consumption is related to food safety, food quality, environmental, safety, and social concerns. Future politics of food will be based on a redefinition of commodity food consumption as an expression of citizenship. “Citizen-consumers” realize that they could use their buying power in order to develop a new terrain of social agency and political action. It takes for granted kinds of moral selfhood in which human responsibility is bound into human agency based on knowledge and recognition. This requires new kinds of food labeling practices. Existing research on consumer’s preferences often fails to recognize the full complexity of the motivations and intentions through which the identity of the moral self is built up in relation to food consumption practices. For citizens, not only food production practices matter but also the impact of what we eat on who we are and the ecological foot print of our food stuff. Two major drivers for this are the idea that we ourselves have to take care of our own bodies (“We are what we eat”) and that we are responsible for Planet Earth. Since both obesity and climate change have become major public concerns, also governments develop an increasing interest in defining how citizens ought to behave as consumers and how retailers and producers should facilitate such responsible behavior. Since they are supposed to defend the “bonum commune,” e.g., the public health of their citizens and a sound common future for all, a new consensus on “appropriate” consumption choices has to be found, balancing beneficence and autonomy.
    Journal of Agricultural and Environmental Ethics 12/2012; 25(6). DOI:10.1007/s10806-011-9366-7 · 1.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Theranostics signals the integrated application of molecular diagnostics, therapeutic treatment and patient response monitoring. Such integration has hitherto neglected another crucial dimension: coproduction of theranostic scientific knowledge, novel technological development and broader sociopolitical systems whose boundaries are highly porous. Nanodiagnostics applications to theranostics are one of the most contested and potentially volatile postgenomics innovation trajectories as they build on past and current tensions and promises surrounding both nanotechnology and personalized medicine. Recent science policy research suggests that beneficial outcomes of innovations do not simply flow from the generation of scientific knowledge and technological capability in a linear or automatic fashion. Thus, attempts to offset public concerns about controversial emerging technologies by expert risk assurances can be unproductive. Anticipation provides a more robust basis for governance that supports genuine healthcare progress. This article presents a synthesis of novel policy approaches that directly inform theranostics medicine and the future(s) of postgenomics healthcare.
    Expert Review of Molecular Diagnostics 11/2012; 12(8):857-70. DOI:10.1586/erm.12.125 · 4.09 Impact Factor